MarketsSingle-source
2.0
Keros Therapeutics reports executive or director departure via 8-K filing
SEC EDGAR 8-K FilingsLO·US·2 days ago
B&R Technology Merger Corp. has filed an 8-K disclosing a material definitive agreement, unregistered equity sales, and changes to its board of directors and corporate bylaws. The filing indicates a significant corporate restructuring or merger-related activity, though specific terms of the agreement remain to be parsed from the full exhibit.